全文获取类型
收费全文 | 11044篇 |
免费 | 885篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 110篇 |
儿科学 | 606篇 |
妇产科学 | 300篇 |
基础医学 | 1691篇 |
口腔科学 | 226篇 |
临床医学 | 1025篇 |
内科学 | 2431篇 |
皮肤病学 | 118篇 |
神经病学 | 984篇 |
特种医学 | 372篇 |
外科学 | 1953篇 |
综合类 | 144篇 |
一般理论 | 3篇 |
预防医学 | 750篇 |
眼科学 | 218篇 |
药学 | 465篇 |
中国医学 | 11篇 |
肿瘤学 | 543篇 |
出版年
2021年 | 95篇 |
2019年 | 106篇 |
2018年 | 136篇 |
2017年 | 114篇 |
2016年 | 112篇 |
2015年 | 133篇 |
2014年 | 223篇 |
2013年 | 307篇 |
2012年 | 400篇 |
2011年 | 419篇 |
2010年 | 236篇 |
2009年 | 215篇 |
2008年 | 422篇 |
2007年 | 384篇 |
2006年 | 378篇 |
2005年 | 456篇 |
2004年 | 427篇 |
2003年 | 365篇 |
2002年 | 384篇 |
2001年 | 367篇 |
2000年 | 352篇 |
1999年 | 300篇 |
1998年 | 108篇 |
1997年 | 103篇 |
1996年 | 94篇 |
1995年 | 100篇 |
1992年 | 283篇 |
1991年 | 271篇 |
1990年 | 284篇 |
1989年 | 296篇 |
1988年 | 275篇 |
1987年 | 283篇 |
1986年 | 264篇 |
1985年 | 253篇 |
1984年 | 170篇 |
1983年 | 189篇 |
1982年 | 124篇 |
1981年 | 124篇 |
1980年 | 112篇 |
1979年 | 220篇 |
1978年 | 191篇 |
1977年 | 148篇 |
1976年 | 162篇 |
1975年 | 140篇 |
1974年 | 142篇 |
1973年 | 145篇 |
1972年 | 150篇 |
1971年 | 108篇 |
1970年 | 102篇 |
1969年 | 116篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Boothe Emily Olenderek Marta Noyola M. Cristina Rushing Julia Allred Erinn Kaplan Sebastian 《Zeitschrift fur Gesundheitswissenschaften》2022,30(6):1373-1380
Journal of Public Health - Group prenatal care provides an alternative model of prenatal care that allows for collaboration with peers, education, discussion, and self-management training in... 相似文献
2.
Implications for Practice
Breast cancer is far more curable than in the past but requires multimodality treatment. Great care must be taken to use the least leukemogenic treatment programs that do not sacrifice efficacy. Elimination of radiation and anthracycline/alkylating agent regimens will be helpful where possible, particularly in younger patients and possibly those with homologous repair deficiency (HRD). Use of colony-stimulating factors should be limited to those who truly require them for safe chemotherapy administration. Further study of a possible leukemogenic association with HRD and the various forms of colony-stimulating factors is badly needed.3.
4.
5.
6.
7.
Kishor Devalaraja-Narashimha Karoline Meagher Yifan Luo Cong Huang Theodore Kaplan Anantharaman Muthuswamy Gabor Halasz Sarah Casanova John OBrien Rebecca Peyser Boiarsky John McWhirter Hans Gartner Yu Bai Scott MacDonnell Chien Liu Ying Hu Adrianna Latuszek Yi Wei Srinivasa Prasad Tammy Huang George Yancopoulos Andrew Murphy William Olson Brian Zambrowicz Lynn Macdonald Lori G. Morton 《Journal of the American Society of Nephrology : JASN》2021,32(1):99
8.
Kaplan Lewis Moheet Asma M. Livesay Sarah L. Provencio J. Javier Suarez Jose I. Bader Mary Kay Bailey Heatherlee Chang Cherylee W. J. 《Neurocritical care》2020,32(2):369-372
Neurocritical Care - The Neurocritical Care Society and the Society of Critical Care Medicine have worked together to create a perspective regarding the Standards of Neurologic Critical Care Units... 相似文献
9.
10.
Michel M. Sun M.D. Ph.D. Ralph D. Levinson M.D. Artur Filipowicz D.O. Stephen Anesi M.D. Henry J. Kaplan M.D. Wei Wang M.D. Ph.D. 《Ocular immunology and inflammation》2020,28(2):217-227
ABSTRACTPurpose: To investigate the link between treatment with CTLA-4 and PD-1 checkpoint blockade inhibitors and the development of noninfectious uveitis.Methods: A survey was distributed to uveitis specialists to identify patients who developed uveitis while receiving either PD-1 inhibitors pembrolizumab and nivolumab; PD-L1 inhibitors atezolizumab, avelumab, and durvalumab; or the CTLA-4 inhibitor ipilimumab.Results: Fifteen patients from seven institutions were identified. The most common cancer diagnosis (13/15) was malignant melanoma. Fourteen patients had a new uveitis diagnosis following checkpoint blockade administration (six anterior uveitis, six panuveitis, one posterior uveitis, one anterior/intermediate combined); one patient developed optic neuritis. Uveitis was diagnosed within 6 months after drug initiation for 11/12 patients (median 63 days). Corticosteroid treatment was effective for most patients, although two patients had permanent loss of vision.Conclusions: Patients on checkpoint inhibitor therapy should be educated to seek care if they develop ocular symptoms, and prompt referral to specialists should be incorporated into oncology protocols. 相似文献